Article
The CIC-ERF co-deletion underlies fusion independent activation of ETS family member…
medRxiv · 2022 · Gupta, N.; Song, H.; Wu, W.; Ponce, R.; Lin, Y.; Kim, J. W.; Small, E.; Feng, F.; Huang, F. W.; Okimoto, R.
Key facts
| Title | The CIC-ERF co-deletion underlies fusion independent activation of ETS family member, ETV1, to drive prostate cancer progression |
|---|---|
| First author | Gupta, N.; Song, H.; Wu, W.; Ponce, R.; Lin, Y.; Kim, J. W.; Small, E.; Feng, F.; Huang, F. W.; Okimoto, R. |
| Journal | medRxiv |
| Published | Jan 28, 2022 |
| DOI | 10.1101/2022.01.26.477820 |
| Devices mentioned | K190495, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 2 more |
| Product codes mentioned | DDG, JJH, PFT |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1